Taiwanese innovation company Innovation to Industry (i2i) has launched the IP² Launchpad program to expose Israeli startups with exposure to the whole ecosystem, and provide a center to launch their activities, validate their technologies and to penetrate the growing East Asian markets with strong strategic partners. The program will invest up to $70 million in Israeli startups with up to $200,000 in the first phase and up to $3 million at the end of the program.
IP² is managed in Israel by the Israeli consulting firm Healthier Globe headed by Rani Shifron, which assists and supports startups and organizations in entering and developing global markets.
The aim of IP² is to create collaboration between Israeli innovation and the technology and healthcare markets in Taiwan, to connect Israeli companies with leading strategic partners from the manufacturing and distribution industries, the healthcare system, R&D organizations and potential investors, as well as to establish the Asian Business and Innovation Center in Taiwan for Israeli companies, to help accelerate their entry into East Asian Markets. The program was kicked off in the wake of the global coronavirus crisis, and from March of this year i2i and Healthier Globe scoured dozens of Israeli companies from which an industry panel selected startups from the fields of digital healthcare (60% of companies), cybersecurity (24%) and AIOT (16%). The companies are in the early stages of sales or in preparation for the market, and most of them are after initial investment rounds. With the launch of the program, eight strategic cooperation agreements were announced and signed between the Israeli startups and the partners in the program. The agreements include piloting, feasibility studies and clinical validation studies.
Source: Globes
